Ayvakit is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Blueprint Medicines Corporation. The primary component is Avapritinib.
| Product ID | 72064-110_5bb10e23-7d74-4b45-86aa-190ef4467b54 |
| NDC | 72064-110 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ayvakit |
| Generic Name | Avapritinib |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-01-09 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212608 |
| Labeler Name | Blueprint Medicines Corporation |
| Substance Name | AVAPRITINIB |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Kinase Inhibitor [EPC],Tyrosine Kinase Inhibitors [MoA],Cytochrome P450 2C9 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA],Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA],Bile Salt Export Pump Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2020-01-09 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA212608 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-01-09 |
| Ingredient | Strength |
|---|---|
| AVAPRITINIB | 100 mg/1 |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 72064-110 | Ayvakit | avapritinib |
| 72064-120 | Ayvakit | avapritinib |
| 72064-125 | Ayvakit | avapritinib |
| 72064-130 | Ayvakit | avapritinib |
| 72064-150 | Ayvakit | avapritinib |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() AYVAKIT 88589364 not registered Live/Pending |
Blueprint Medicines Corporation 2019-08-22 |
![]() AYVAKIT 88478478 not registered Live/Pending |
Blueprint Medicines Corporation 2019-06-18 |